Background: The central role that the thalamus plays in information process
ing and sensory integration suggests that its dysfunction may be a factor i
n the pathophysiology of schizophrenia. Glutamate is a key neurotransmitter
in thalamic function, and although ail aspects of thalamic glutamate neuro
transmission have nor been elucidated, transcripts encoding members of each
family of the glutamate receptors have been identified in rite thalamus. R
ecently, activation of group II metabotropic glutamate receptors (mGluRs) w
as demonstrated in mts to ameliorate the behavioral effects associated with
exposure to phencyclidine, an uncompetitive NMDA receptor antagonist that
can induce psychotic symptoms, suggesting the possibility of mGluR abnormal
ities in schizophrenia. We investigated whether expression of thalamic mGlu
R mRNA is altered in this illness.
Methods: We examined the expression of the transcripts encoding the mGluR1,
2, 3, 4, 5, 7, and 8 receptors in postmortem thalamic tissue samples from
elderly schizophrenic and control subjects, using in situ hybridization. We
identified six thalamic nuclei in each section (anterior; dorsomedial, lat
eral dorsal, central medial, reticular, and nuclei of the ventral tier).
Results: There were no differences between elderly schizophrenic and contro
l subjects in the expression of mGluR1, 2, 3, 4, 5, 7, or 8 transcript leve
ls ill any of these six thalamic nuclei.
Conclusions: mGluR mRNA expression is nor abnormal in rite thalamus of pati
ents with schizophrenia. The modulatory roles proposed for mGluRs, and the
potentially important relationship between mGluRs and NMDA receptors, sugge
st that mGluRs may be involved in the pathophysiology of schizophrenia, bla
t this is not detectable at this level of gene expression. (C) 1999 Society
of Biological Psychiatry.